Legislation
- Title
- Prescription Drug Monitoring Program - Program Evaluation
- Sponsored by
- Chair, Finance Committee
- Status
- In the Senate - Hearing 2/14 at 1:00 p.m.
- Analysis
- Fiscal and Policy Note
Synopsis
Requiring the Prescription Drug Monitoring Program to provide prescription monitoring data to authorized users, rather than the authorized administrator, of another state's prescription drug monitoring program; repealing the termination date of the Program; repealing the requirement that the Department of Legislative Services conduct a certain evaluation of the Program under the Maryland Program Evaluation Act; etc.
Committees
- Original:
- Finance
Details
(
21-2A-06, 21-2A-10 )
(
8-403 )
Last Updated: 2/3/2020 2:33 PM